News

ThredUp's 2024 Performance: Growth and Strategic Developments

ThredUp's 2024 Performance: Growth and Strategic Developments

ThredUp's Financial Results for 2024

In a significant stride towards growth and sustainability, ThredUp Inc. (NASDAQ: TDUP) released its financial results for the fourth quarter and the entire year of 2024. This announcement underlines the company’s commitment to transforming the resale market, making secondhand shopping more accessible and sustainable for consumers worldwide.

Quarterly Performance Highlights

Robust Revenue Growth

ThredUp reported a remarkable quarterly revenue of $67.3 million, indicating a 9% increase compared to the same quarter from the previous year. This growth reflects the effectiveness of ThredUp’s innovative strategies to attract customers to its platform.

Improved Gross Margins

The fourth quarter also saw a record gross margin of 80.4%. This impressive metric not only showcases ThredUp’s efficiency but also its strong positioning within the competitive resale market, allowing for better profitability.

Active User Engagement

Despite the challenges faced in the previous year, ThredUp ended the quarter with 1,274 thousand active buyers, although there was a decrease of 6% year-over-year. Nonetheless, the number of orders placed increased by 2%, highlighting a positive trend in customer engagement during the holiday shopping season.

Annual Financial Overview

Full Year Revenue Highlights

For the entire year 2024, ThredUp posted a total revenue of $260 million, reflecting a growth of 1% year-over-year. The company’s gross margin for the full year stood at a solid 79.7%, further validating its strategic business decisions and enhanced operational efficiencies.

Operational Losses

Despite the positive trends in revenue and margins, ThredUp experienced a loss from continuing operations amounting to $40 million for the full fiscal year 2024. However, this represents an improvement compared to the loss of $52.4 million in 2023, which is an encouraging sign as the company heads into 2025.

Strategic Developments and Future Outlook

Divestiture and Business Focus

In a strategic move, ThredUp divested 91% of its European business, including its Bulgarian subsidiary, Remix Global EAD. This decision was a significant step to streamline operations and focus on core market segments. The company anticipates that this will allow for more structured growth in its continuing operations.

Marketing and Customer Experience Enhancements

The company implemented customer experience updates that resulted in ThredUp achieving record new buyer acquisition during Q4. The introduction of features like image search has helped boost conversion rates significantly - up to 85% as compared to traditional searching methods.

Financial Forecast for 2025

Looking forward to the first quarter of 2025, ThredUp anticipates revenue to reach between $67.5 million and $69.5 million, projecting an overall growth of approximately 6% year-over-year. Moreover, the company expects a gross margin between 77.0% and 79.0% during this period.

For the full year of 2025, ThredUp projects a revenue range of $270 million to $280 million, maintaining the growth trajectory from the previous year. This is complemented by expectations for a consistent gross margin similar to that of 2024.

Investors and Media Relations

Investors can reach out to ThredUp through their dedicated email at ir@thredup.com. For media inquiries, please contact media@thredup.com. ThredUp remains committed to transparency and continual communication with its stakeholders as it navigates the evolving dynamics of the resale market.

Frequently Asked Questions

What were ThredUp's total revenues for Q4 2024?

ThredUp reported total revenues of $67.3 million for the fourth quarter of 2024.

How did ThredUp's gross margin perform in 2024?

The gross margin for ThredUp was an impressive 80.4% in the fourth quarter and 79.7% for the full year of 2024.

What major strategic move did ThredUp make in 2024?

ThredUp divested 91% of its European business, including Remix Global EAD, to focus on its core operations.

How many active buyers did ThredUp end 2024 with?

ThredUp had 1,274 thousand active buyers at the end of Q4 2024.

What are ThredUp's revenue projections for 2025?

ThredUp expects revenue to be in the range of $270 million to $280 million for the full fiscal year 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 79

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 72

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 140

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 93

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 312

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 87

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Nippon Express Europe Partners with Formag for Logistics Support

Updated Category News Views 213

Nippon Express Europe and Formag Form New Logistics Partnership Nippon Express Europe GmbH, part of NIPPON EXPRESS HOLDINGS, INC., has recently signed a cooperation agreement with Ukrainian logistics provider, Formag-Kiev. This significant collaboration aims to provide essential logistical support for the reconstruction of Ukraine. Commitment to Ukrainian Reconstruction...

Continue Reading
Escalating Legal Action Over LIBRA Token Sparks Controversy

Updated Category News Views 265

Legal Developments in the LIBRA Token Case A prominent Argentine lawyer has made headlines by calling for global law enforcement to apprehend a cryptocurrency figure involved in the LIBRA token controversy. Details of the Extradition Request Gregorio Dalbon, known for his defense work with former Argentine President Cristina Fernandez in a prominent corruption matter, has...

Continue Reading
Tesla Prevails in Motion to Dismiss Racial Bias Lawsuit

Updated Category News Views 230

Tesla's Legal Victory Against Racial Bias Allegations Under the direction of Elon Musk, Tesla Inc. (NASDAQ: TSLA) has successfully overturned a significant class action lawsuit that was brought forth by more than 6,000 African American workers. These workers alleged racial discrimination at Tesla's Fremont assembly plant. This ruling is a key moment in the ongoing...

Continue Reading
ZenaTech Unveils Specialized AI Hub to Bolster US Defense Tactics

Updated Category News Views 100

ZenaTech Launches Innovative AI Development Center Vancouver, British Columbia – ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) has taken a significant stride toward advancing artificial intelligence technologies by establishing Zena AI, Inc. This new AI Development Center will focus on crafting specialized AI solutions tailored for defense and homeland security...

Continue Reading
Investors Reminded of Action Timeline Against ICON plc - ICLR

Updated Category News Views 172

Understanding the Legal Proceedings Against ICON plc In an important reminder for shareholders, Kahn Swick & Foti, LLC is emphasizing the critical timeline for investors affected by losses from their holdings in ICON plc (NASDAQ: ICLR). The firm, led by former Louisiana Attorney General Charles C. Foti, Jr., is urging investors who incurred losses exceeding $100,000 to...

Continue Reading